US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

640.36

-28.0263-4.19%

Number of Gainers:44

Number of Losers:110

Number of Flat:13

PE:- -

High:668.38

Open:668.38

Low:634.70

Close:668.38

Volume:324.50M

Turnover:10.92B

Market Cap:480.25B

Float Cap:346.21B

Loading ...

D-Market files initial beneficial ownership statement for Logistics CEO Hakan Karadogan

D-Market files Form 3 initial beneficial ownership statement for CEO Nilhan Gokcetekin

Daily Fortune | March 24th

Avalo Therapeutics: Attractive Risk‑Reward in Hidradenitis Suppurativa Driven by Abdakibart’s Differentiated IL‑1β Profile and Upcoming Phase 2 LOTUS Readout

Citi opens ‘upside 90-day catalyst watch’ on Travere Therapeutics

PYC Therapeutics Advances ADOA Drug PYC-001 With New Clinical Data and Ongoing Trial

Travel stocks are among the biggest gainers as Trump teases Iran talks

A Look At Oklo (OKLO) Valuation After Key Reactor And Fuel Cycle Milestones

Simply Wall St.

Rain on the horizon threatens RAIN’s community Bush Bash gig

The West Australian

Percheron Therapeutics Launches Discounted Entitlement Offer, Excludes Overseas Holders

Orange County Bancorp President and CEO Michael J. Gilfeather acquires USD 1,223,398 of common shares

Alignment Healthcare CEO John E. Kao disposes of USD 2,062,439 in common shares

Outlook Therapeutics Announces Proposed Public Offering

Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis

Context Therapeutics FY Net Loss Narrows

MT Newswires Live

Context Therapeutics Highlights Evolving T Cell Engager Pipeline

Intensity Therapeutics Expands ATM Equity Offering Capacity

Phillips Edison & Co. Inc. publishes 2025 annual report

Mixed options sentiment in Robinhood with shares up 2.32%

Top News Today/Canada: Bank of Canada to Lose Two Members of Rate-Setting Governing Council

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4539/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":640.35693,"timestamp":1774382399999,"preClose":668.38324,"halted":0,"volume":324501998,"delay":0,"changeRate":-0.041931,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-28.026306,"latestTime":"03-24 16:00:00 EDT","open":668.3818,"high":668.3818,"low":634.69696,"amount":10921926979.27235,"amplitude":0.050397,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774396800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.376015,"peRate":176.12387,"turnoverRate":0.023072,"increases":44,"decrements":110,"flats":8,"marketCap":480253958362.125,"floatMarketCap":346212292848},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":668.3818,"amplitude":0.050397,"preClose":668.38324,"low":634.69696,"pbRate":"5.376015","latestPrice":640.35693,"volume":324501998,"delay":0,"open":668.3818,"prevYearClose":881.5255,"prevWeekClose":652.8748,"prevMonthClose":663.4647,"prevQuarterClose":881.5255,"fiveDayClose":684.654,"twentyDayClose":633.0492,"sixtyDayClose":928.8742,"secType":"PLATE","market":"US","turnoverRate":0.023072,"peRate":176.12387,"marketCap":480253958362.125,"floatMarketCap":346212292848,"timestamp":1774382399999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":44,"down":110,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2621103564","title":"D-Market files initial beneficial ownership statement for Logistics CEO Hakan Karadogan","url":"https://stock-news.laohu8.com/highlight/detail?id=2621103564","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621103564?lang=en_us&edition=fundamental","pubTime":"2026-03-24 08:20","pubTimestamp":1774311603,"startTime":"0","endTime":"0","summary":"Hakan Karadogan, CEO of Logistics at D-Market, filed an initial statement of beneficial ownership reporting 100,000 restricted stock units.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. D-Market Elektronik Hizmetler ve Ticaret AS published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL4k1Ynk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","HEPS","BK4220","BK4122"],"gpt_icon":0},{"id":"2621035558","title":"D-Market files Form 3 initial beneficial ownership statement for CEO Nilhan Gokcetekin","url":"https://stock-news.laohu8.com/highlight/detail?id=2621035558","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621035558?lang=en_us&edition=fundamental","pubTime":"2026-03-24 08:18","pubTimestamp":1774311519,"startTime":"0","endTime":"0","summary":"Nilhan Gokcetekin, chief executive officer of D-Market Electronic Services and Trading, filed an initial statement of beneficial ownership dated 03/18/2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. D-Market Elektronik Hizmetler ve Ticaret AS published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL3sP0dD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","HEPS","BK4122","BK4220"],"gpt_icon":0},{"id":"1124935546","title":"Daily Fortune | March 24th","url":"https://stock-news.laohu8.com/highlight/detail?id=1124935546","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124935546?lang=en_us&edition=fundamental","pubTime":"2026-03-24 07:52","pubTimestamp":1774309924,"startTime":"0","endTime":"0","summary":"Image source: Xiaohongshu @千山之危  \nSource: Cailian News  \nAuthor: Wu Guanzheng\nMassive information and precise analysis, all available on the SINA Corp Finance App.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4608","LU2360106780.USD","LU1861215975.USD","LU0097036916.USD","LU0353189763.USD","APP","IE00B894F039.SGD","BK4023","LU0056508442.USD","LU2290526834.HKD","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU2360107168.USD","APPX","LU2063271972.USD","BK4613","LU1861220033.SGD","LU1852331112.SGD","SINA","BK4588","BK4539","LU0353189680.USD","LU2087625088.SGD","LU2250418816.HKD","IE00BZ9MQY76.HKD"],"gpt_icon":0},{"id":"2621203332","title":"Avalo Therapeutics: Attractive Risk‑Reward in Hidradenitis Suppurativa Driven by Abdakibart’s Differentiated IL‑1β Profile and Upcoming Phase 2 LOTUS Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=2621203332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621203332?lang=en_us&edition=fundamental","pubTime":"2026-03-24 07:36","pubTimestamp":1774308961,"startTime":"0","endTime":"0","summary":"Analyst Julian Harrison from BTIG maintained a Buy rating on Avalo Therapeutics and keeping the price target at $40.00. Julian Harrison has given h...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/avalo-therapeutics-attractive-risk‑reward-in-hidradenitis-suppurativa-driven-by-abdakibarts-differentiated-il‑1β-profile-and-upcoming-phase-2-lotus-readout-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/avalo-therapeutics-attractive-risk‑reward-in-hidradenitis-suppurativa-driven-by-abdakibarts-differentiated-il‑1β-profile-and-upcoming-phase-2-lotus-readout-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2621334033","title":"Citi opens ‘upside 90-day catalyst watch’ on Travere Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2621334033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621334033?lang=en_us&edition=fundamental","pubTime":"2026-03-24 07:25","pubTimestamp":1774308338,"startTime":"0","endTime":"0","summary":"Citi added an “upside 90-day catalyst watch” on shares of Travere Therapeutics (TVTX) while keeping a Buy rating on the name with a $48 price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-opens-upside-90-day-catalyst-watch-on-travere-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-opens-upside-90-day-catalyst-watch-on-travere-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVTX","LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2621080189","title":"PYC Therapeutics Advances ADOA Drug PYC-001 With New Clinical Data and Ongoing Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2621080189","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621080189?lang=en_us&edition=fundamental","pubTime":"2026-03-24 06:17","pubTimestamp":1774304270,"startTime":"0","endTime":"0","summary":"PYC Therapeutics Limited ( ($AU:PYC) ) just unveiled an announcement. PYC Therapeutics has highlighted progress in its clinical pipeline with new d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-advances-adoa-drug-pyc-001-with-new-clinical-data-and-ongoing-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-advances-adoa-drug-pyc-001-with-new-clinical-data-and-ongoing-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2621080648","title":"Travel stocks are among the biggest gainers as Trump teases Iran talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2621080648","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621080648?lang=en_us&edition=fundamental","pubTime":"2026-03-24 06:11","pubTimestamp":1774303860,"startTime":"0","endTime":"0","summary":"Shares of cruise companies were among Monday's top gainers as President Donald Trump backtracked on threats to Iran.Travel-related stocks such as airlines and cruise companies rallied Monday after President Donald Trump postponed his deadline for more strikes in Iran, saying the two countries had held \"very good and productive\" talks - something Iranian media reports rebuffed.Among the stocks gaining the most, low-cost Frontier Airlines parent Frontier Group  rallied more than 9% and United Airlines  rose nearly 5%. Norwegian Cruise Line  was up more than 6%, while shares of car-rental companies Hertz Global  rose 4.6% and Avis Budget  gained more than 7%. That takes some of the sting out of March losses, which for most travel-related companies are in the double digits.Trump said he is pausing his threat to destroy Iran's power plants and other infrastructure for five days. Iran had issued retaliation threats of its own. Crude-oil futures headed lower on Monday.Frontier is the only air","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR","XOP","ULCC","HTZ","BK4500","BK4008","DAL","BK4230","LU0310800965.SGD","LU1267930227.SGD","IE00BFMHRM44.USD","LU0052756011.USD","BK4585","BK4588","BK4539","BK4517","LU0128525689.USD","UAL","BK4142","BK4022","DUG","NCLH"],"gpt_icon":1},{"id":"2621038652","title":"A Look At Oklo (OKLO) Valuation After Key Reactor And Fuel Cycle Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2621038652","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621038652?lang=en_us&edition=fundamental","pubTime":"2026-03-24 06:08","pubTimestamp":1774303720,"startTime":"0","endTime":"0","summary":"Oklo (OKLO) has entered a busy phase, signing a U.S. Department of Energy agreement for its first Aurora reactor, advancing fuel facility approvals, and exploring a Centrus joint venture as investors reassess the stock.\nSee our latest analysis for Oklo.\nAfter a sharp run that left shareholders with a 1 year total shareholder return of 82.01% and a very large 3 year total shareholder return, momentum has cooled, with a 90 day share price return of a 31.29% decline. This comes even as recent...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9521000-choice2-main-header/1585186610142","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9521000-choice2-main-header/1585186610142"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/utilities/nyse-oklo/oklo/news/a-look-at-oklo-oklo-valuation-after-key-reactor-and-fuel-cyc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/utilities/nyse-oklo/oklo/news/a-look-at-oklo-oklo-valuation-after-key-reactor-and-fuel-cyc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4539","BK4081","OKLO","OKLL","BK4606","OKLS"],"gpt_icon":1},{"id":"2621055970","title":"Rain on the horizon threatens RAIN’s community Bush Bash gig","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055970","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621055970?lang=en_us&edition=fundamental","pubTime":"2026-03-24 06:00","pubTimestamp":1774303200,"startTime":"0","endTime":"0","summary":"The weather forecast is threatening the 2026 Bush Bash, a bushfire recovery and farmer unwinding event scheduled for Saturday at the Old Fitzgerald School Site between Ravensthorpe and Jerramungup.","market":"hk","thumbnail":"https://images.thewest.com.au/publication/C-22038831/013ad2411acfd63d0d892ce8a59d70946c0c4c3b.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22038831/013ad2411acfd63d0d892ce8a59d70946c0c4c3b.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/news/great-southern-herald/weather-threatens-rain-bush-bash-event-with-postponement-delaying-chance-for-community-to-take-a-breather-c-22038831","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/news/great-southern-herald/weather-threatens-rain-bush-bash-event-with-postponement-delaying-chance-for-community-to-take-a-breather-c-22038831","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK4539","BK4161","BK4007","RAIN"],"gpt_icon":0},{"id":"2621080826","title":"Percheron Therapeutics Launches Discounted Entitlement Offer, Excludes Overseas Holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2621080826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621080826?lang=en_us&edition=fundamental","pubTime":"2026-03-24 05:52","pubTimestamp":1774302768,"startTime":"0","endTime":"0","summary":"Percheron Therapeutics ( ($AU:PER) ) has shared an announcement. Percheron Therapeutics has launched a non-renounceable pro-rata entitlement offer,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-launches-discounted-entitlement-offer-excludes-overseas-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/percheron-therapeutics-launches-discounted-entitlement-offer-excludes-overseas-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2621087204","title":"Orange County Bancorp President and CEO Michael J. Gilfeather acquires USD 1,223,398 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2621087204","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621087204?lang=en_us&edition=fundamental","pubTime":"2026-03-24 05:43","pubTimestamp":1774302205,"startTime":"0","endTime":"0","summary":"Orange County Bancorp director, President and CEO Michael Gilfeather reported receiving 16,853 shares of common stock at a price of USD 0.He also reported receiving 9,438 shares at a price of USD 0.A separate transaction reported a disposition of 6,189 shares at USD 31.15 per share.An IRA reported an acquisition of 200 shares at USD 31.25 per share, bringing that holding to 16,400 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orange County Bancorp Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL7vsT4m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Orange County Bancorp President and CEO Michael J. Gilfeather acquires USD 1,223,398 of common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBT","BK4211","BK4539"],"gpt_icon":0},{"id":"2621087414","title":"Alignment Healthcare CEO John E. Kao disposes of USD 2,062,439 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2621087414","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621087414?lang=en_us&edition=fundamental","pubTime":"2026-03-24 05:37","pubTimestamp":1774301841,"startTime":"0","endTime":"0","summary":"John E. Kao, Chief Executive Officer and director at Alignment Healthcare, reported a sale of 118,000 common shares.The shares were sold at a weighted-average price of USD 17.48 per share.Following the transaction, he reported indirect ownership of 2,354,641 shares and direct ownership of 1,784,868 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alignment Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL8h4PTy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alignment Healthcare CEO John E. Kao disposes of USD 2,062,439 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","ALHC","BK4539"],"gpt_icon":0},{"id":"2621743038","title":"Outlook Therapeutics Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2621743038","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621743038?lang=en_us&edition=fundamental","pubTime":"2026-03-24 05:30","pubTimestamp":1774301400,"startTime":"0","endTime":"0","summary":"ISELIN, N.J., March  23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260887/0/en/Outlook-Therapeutics-Announces-Proposed-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2621087470","title":"Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2621087470","media":"prnewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621087470?lang=en_us&edition=fundamental","pubTime":"2026-03-24 05:30","pubTimestamp":1774301400,"startTime":"0","endTime":"0","summary":"CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS. SYDNEY, March 24, 2026 /PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announced dosing of the first participant in its Phase 1b KOANEWA trial evaluating CTx1000, an investigational genetic medicine targeting pathological forms of the TDP-43 protein in people with amyotrophic lateral sclerosis , also known as motor neuron disease . The study is being conducted at the Neurology Department of Macquarie University Hospital in Sydney, Australia.Dr Kathryn Sunn, Chief Executive Officer at Celosia Therapeutics, said: \"ALS is a progressive and ultimately fatal neurodegenerative disease with limited therapeutic options. The initiation of dosing in the KOANEWA study marks an important milestone for Celosia and, most importantly, for the ALS community. Treating the first patient begins the clinical evaluation of this genetic ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/celosia-therapeutics-announces-first-patient-dosed-in-phase-1b-clinical-trial-of-ctx1000-in-amyotrophic-lateral-sclerosis-302721818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7055","BK4007","BK4539","BK4139","MND.AU","LENZ"],"gpt_icon":0},{"id":"2621082934","title":"Context Therapeutics FY Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2621082934","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621082934?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:52","pubTimestamp":1774299120,"startTime":"0","endTime":"0","summary":"Context Therapeutics  reported a FY net loss of $0.38 per diluted share late Monday, narrowing from a loss of $0.46 a year earlier.Analysts polled by FactSet expected a loss of $0.35.The company ended the year with $94.4 million in cash and equivalents. It expects this will be sufficient to fund operations into mid-2027.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4007","LENZ","CNTX","BK4139"],"gpt_icon":0},{"id":"2621223082","title":"Context Therapeutics Highlights Evolving T Cell Engager Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2621223082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621223082?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:49","pubTimestamp":1774298978,"startTime":"0","endTime":"0","summary":"Context Therapeutics ( ($CNTX) ) just unveiled an update. On March 23, 2026, Context Therapeutics Inc. updated its corporate presentation for inves...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/context-therapeutics-highlights-evolving-t-cell-engager-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/context-therapeutics-highlights-evolving-t-cell-engager-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","CNTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2621822950","title":"Intensity Therapeutics Expands ATM Equity Offering Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2621822950","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621822950?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:43","pubTimestamp":1774298594,"startTime":"0","endTime":"0","summary":"Intensity Therapeutics, Inc. ( ($INTS) ) has issued an update. On March 23, 2026, Intensity Therapeutics, Inc. increased the capacity of its existi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intensity-therapeutics-expands-atm-equity-offering-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intensity-therapeutics-expands-atm-equity-offering-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","BK4139","EQR","BK4588","LENZ","BK4215","BK4007"],"gpt_icon":0},{"id":"2621387082","title":"Phillips Edison & Co. Inc. publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2621387082","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621387082?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:42","pubTimestamp":1774298534,"startTime":"0","endTime":"0","summary":"Phillips Edison reported continued focus on grocery-anchored neighborhood shopping centers, with most annualized base rent coming from grocery-anchored centers and anchors that rank #1 or #2 by sales in their markets.Operational updates cited high leased portfolio occupancy of 97.3% and a portfolio retention rate of 93%.Leasing activity included 1,026 executed leases totaling about 6.0 million square feet, alongside comparable rent spreads of 30.9% on new leases and 20.7% on renewals.Transaction activity included about USD 400 million in gross asset acquisitions, spanning 18 shopping centers plus an outparcel and land for future development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phillips Edison & Co. Inc. published the origina","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL6KfQCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PECO","BK4231","BK4539","BK4080"],"gpt_icon":0},{"id":"2621084741","title":"Mixed options sentiment in Robinhood with shares up 2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084741","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621084741?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:31","pubTimestamp":1774297883,"startTime":"0","endTime":"0","summary":"Mixed options sentiment in Robinhood (HOOD), with shares up $1.65, or 2.32%, near $72.53. Options volume roughly in line with average with 214k con...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-robinhood-with-shares-up-2-32-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-robinhood-with-shares-up-2-32-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","HODU","HOOX","HOOZ","HOOW","HOII","HOOY","HOYY","LU1861559042.SGD","BK4547","BK4539","LU1861558580.USD","HOOG","HOOD","ROBN","HOOI"],"gpt_icon":0},{"id":"2621084103","title":"Top News Today/Canada: Bank of Canada to Lose Two Members of Rate-Setting Governing Council","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084103","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621084103?lang=en_us&edition=fundamental","pubTime":"2026-03-24 04:30","pubTimestamp":1774297800,"startTime":"0","endTime":"0","summary":"The Bank of Canada said that two members of its rate-setting governing council are departing, and it intends to fill the vacancies internally.The central bank said that Deputy Governor Rhys Mendes would leave on April 10, to relocate to Toronto with his family. He was responsible for the central bank's analysis of international economic developments.Deputy Governor Sharon Kozicki intends to retire on July 15, following a two-decade career at Canada's central bank. She was responsible for overseeing analysis of domestic economic developments.BOC Speech Takes on Heightened Importance Amid Rapid Turn in Rate Expectations. LaGuardia Airport Reopens Hours After Deadly Runway Collision. New York City's LaGuardia Airport was closed Monday after a passenger jet collided with an emergency vehicle on the runway, killing two pilots and injuring dozens of other people.The two pilots of the Air Canada Express plane were killed in the crash shortly before midnight Sunday, and a further 41 people, in","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACHV","PVL","BK4082","INTZ","AIRJ","LU1923621640.USD","LU2065170008.USD","ATOS","BK4007","BK4023","BK4539","BK4198","BK4139","COLFF","KBH","ABSI","BK4161","IE00B19Z4B17.USD","LU2125910336.SGD","BK4104","BZAI","MXCT","EPSN","LU2125910179.SGD","IE00B7SZL793.SGD","NKTX","CNM","LU2065169927.USD","KZR","BK4187","BK4141","CNXC","TIL","PAYS","BK4135","SFES","IE0009354923.USD","LU2089985449.USD","BK4505","ECTM","LU2065171402.SGD","BRZE","AIR","SMTI","LENZ","GUTS","SFD","BK4572","BK4213","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":74,"pageCount":8,"totalSize":1469,"code":"91000000","status":"200"}]}}